Mukesh Ambani led Reliance Industry sees over Rs 4 lakh cr decline in market cap from July highs

Reliance Industries has shed nearly $50 billion (Rs 4.2 lakh crore) in market capitalization since its peak in July, as weak earnings and economic challenges weigh on the conglomerate led by billionaire Mukesh Ambani. The refining-to-retail giant’s shares have remained stagnant this year, underperforming the NSE Nifty 50 Index by the widest margin in a decade.

Market Valuation Erosion

Reliance’s market valuation dropped by Rs 50,205.1 crore, bringing it to Rs 17,61,914.95 crore. This decline came as India’s Sensex index sank almost 942 points to a three-month low, and the Nifty index fell over 1%, closing below 24,000. Heavy selling in Reliance and banking shares contributed to the broader market downturn on November 4.

Factors that led to fall in markets

The market slide is partly attributed to speculation around China’s potential economic stimulus package, which stirred concerns over its impact on Indian stocks.

Overseas investor sell-offs have created additional pressure, according to analysts, further affecting sentiment. Key stocks like Adani Ports and Reliance Industries recorded losses, though Mahindra & Mahindra and Infosys managed gains.

Earnings worries and key trends

The recent slump in Reliance shares follows its sixth consecutive earnings miss in the previous quarter, attributed to a subdued demand environment for its flagship oils-to-chemicals segment. 

Despite the decline, Indian markets remain among Asia’s top performers in 2024, despite increasing investor caution amid broader market pressures.

RIL: Key developments and investor sentiment

Reliance’s annual shareholders’ meeting in August included a one-for-one bonus share issue, but left investors without updates on the anticipated listings of its telecom and retail units. 

Further impacting sentiment, its telecom arm, Reliance Jio Infocomm Ltd., lost subscribers in August after a tariff increase, adding to the mixed outlook for the company.

(Disclaimer: Views, recommendations, and opinions expressed are personal and do not reflect the official position or policy of Financial Express.com. Readers are advised to consult qualified financial advisors before making any investment decisions. Reproducing this content without permission is prohibited.)

(With Bloomberg Inputs)

 » Read More

Related Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs. 3,230 Cr, up by 24% YoY and domestic revenue at INR 2,773 Cr, up 17%, Exports at INR 457 Cr, up 121% YoY. The company’s